Saturday, 5 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 17, 2026

JPMorgan Chase (JPM) Stock After 25% Yearly Gain Is The Price Still Reasonable

View original at finance.yahoo.com
JPMorgan Chase (JPM) Stock After 25% Yearly Gain Is The Price Still Reasonable Never miss an important update on your stock portfolio and cut through the noise…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Analysts estimate a stable earnings figure of US$24.65 per share and a stable book value of US$145.37 per share for JPMorgan Chase, based on forward-looking ROE inputs from 12 analysts

    60% confidence
  • The average Return on Equity used in the Excess Returns model is 16.96%, with a cost of equity of US$11.65 per share and an excess return of US$13.00 per share

    60% confidence
  • Over 7 million investors trust Simply Wall St for stock portfolio updates

    60% confidence
  • JPMorgan Chase stock is approximately 24.0% undervalued based on the Excess Returns valuation model, with an intrinsic value estimate of US$435.81 per share versus a market price of US$331.14

    60% confidence
  • JPMorgan Chase scores just 2 out of 6 on Simply Wall St's valuation checks, with multiple red flags identified

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
JPMorgan Chase (JPM) Stock After 25% Yearly Gain Is The Price Still Reasonable — Source | Via News | ViaNews EU